Skip to main content

Table 2 Comparison of sacroiliac joint relaxation time

From: Monitoring the efficacy of tumor necrosis factor alpha antagonists in the treatment of Ankylosing spondylarthritis: a pilot study based on MR relaxometry technique

 

Control group

Case group

Inactive group

Active group

T1-mapping(ms) Sacral

240.33(228.93, 274.57)

473.73(328.33, 956.43)

338.40(285.17, 404.48)

529.87(369.17, 1022.23)

T1-mapping(ms) iliac

233.67(223.93, 257.27)

480.03(351.73, 830.07)

347.55(294.34, 398.93)

598.77(370.13, 865.83)

Z

 − 0.284

 − 1.092

 − 0.933

 − 1.422

P

0.776

0.275

0.351

0.155

T2-mapping(ms) Sacral

104.63(95.13, 107.13)

107.73(93.23, 119.03)

106.73(99.44, 117.17)

108.03(90.73, 121.43)

T2-mapping(ms) iliac

101.03(93.63, 105.33)

103.23(89.37, 117.67)

111.50(97.28, 129.36)

102.23(88.67, 110.83)

Z

 − 0.795

 − 1.134

 − 0.859

 − 1.596

P

0.427

0.257

0.391

0.111

T2*-mapping(ms) Sacra

6.17(5.47, 7.13)

7.87(6.53, 9.93)

7.33(6.16, 8.18)

8.23(6.53, 10.57)

T2*-mapping(ms) iliac

6.33(5.57, 6.8)

7.63(6.53, 8.93)

7.20(6.53, 7.86)

7.83(6.67, 9.73)

Z

 − 0.057

 − 1.769

 − 0.342

 − 1.698

P

0.955

0.077

0.732

0.089